The University of Wisconsin Comprehensive Cancer Center is a matrix center that works with other departments in the medical school in planning and implementing cancer programs, fostering recruitments of key faculty, and providing space and resources for faculty in center programs. The UWCCC has as its major mission the development of fundamental knowledge and fostering interactive laboratory and clinical research. The research is aimed at improving our basic understanding of neoplastic diseases and ways to prevent the disease or improve the outcomes for patients with cancer. The cancer center programs all have a spectrum of activities that range from basic laboratory studies to clinical or control applications. The center programs reach out into 31 different departments and 7 colleges and involve 144 members. The center impacts on clinical care by fostering research in major diseases, such as urologic, breast, and pediatric cancers, or offering our patients new experimental therapies, stressing the appropriate application of pain control and emphasizing research in cancer prevention. Coordination is achieved by providing support for senior and program leaders, excellent shared services, adequate space for both clinical and lab research, a strong biostatistics and computer resource, and administrative support. The UWCCC investigators have been key players in developing many new cancer drugs, biologic response modifiers and chemoprevention agents. The basic research programs all include activities that relate to human cancers such as bladder, prostate and breast cancers, focussed on finding out why these cancers start, how to treat them or prevent their occurrence. Recently an increasing emphasis has been on prevention. UW investigators have been in the forefront of prevention research with the introduction and safety testing of tamoxifen as a chemopreventive agent for breast cancer. The UWCCC impacts on clinical research in the community through a variety of mechanisms. These include the affiliate programs of ECOG and the regional council of cancer organizations who work through the council to implement cancer control research. The UWCCC collaborates with the state Division of Health developing statewide programs in pain control, smoking cessation, tumor reporting, and breast screening. UWCCC intends to strengthen its current fundamental research efforts. The disciplines of nursing and surgical oncology require nurturing. The UWCCC sees prevention as an important area of expanded effort The UWCCC will continue to look for strategies in the lab and take these to the clinic. The CCSG proposal requests support for these current and developmental research thrusts, the program leaders and essential research shared resources.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-25
Application #
2390618
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1976-01-01
Project End
1998-03-31
Budget Start
1997-04-25
Budget End
1998-03-31
Support Year
25
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Schumacher, Jessica R; Neuman, Heather B; Chang, George J et al. (2018) A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol 25:2587-2595
Turk, Anita A; Wisinski, Kari B (2018) PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside. Cancer 124:2498-2506
Liu, Ting; Shi, Changzheng; Duan, Linqi et al. (2018) A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis. J Mater Chem B 6:4756-4764
Zhan, Yonghua; Ehlerding, Emily B; Shi, Sixiang et al. (2018) Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging. J Biomed Nanotechnol 14:900-909
Bloom, Debra D; Reshetylo, Sofiya; Nytes, Cassandra et al. (2018) Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. J Immunother 41:213-223
Wei, Weijun; Jiang, Dawei; Ehlerding, Emily B et al. (2018) Noninvasive PET Imaging of T cells. Trends Cancer 4:359-373
Fricke, Stephanie L; Payne, Susan N; Favreau, Peter F et al. (2018) MTORC1/2 inhibition as a therapeutic strategy for PIK3CA mutant cancers. Mol Cancer Ther :
Feld, Shara I; Fan, Jun; Yuan, Ming et al. (2018) Utility of Genetic Testing in Addition to Mammography for Determining Risk of Breast Cancer Depends on Patient Age. AMIA Jt Summits Transl Sci Proc 2017:81-90
Hernández-Santos, Nydiaris; Wiesner, Darin L; Fites, J Scott et al. (2018) Lung Epithelial Cells Coordinate Innate Lymphocytes and Immunity against Pulmonary Fungal Infection. Cell Host Microbe 23:511-522.e5
van Ravesteyn, Nicolien T; van den Broek, Jeroen J; Li, Xiaoxue et al. (2018) Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches. Med Decis Making 38:126S-139S

Showing the most recent 10 out of 1528 publications